[Event Report] Global Expert Meeting “Race Against Resistance – What Will Happen When Drug Resistance Spreads?” (April 23, 2024)
date : 5/10/2024
Tags: AMR
Antimicrobial Resistance (AMR) is causing widespread disruption, with approximately 1.27 million estimated annual deaths directly linked to AMR, as a British medical journal reported in 2022. AMR has been called a “silent pandemic” and “The next threat after COVID-19.” The lack of progress in developing new antimicrobials has revealed the necessity of international cooperation and the importance of pursuing a One Health approach among G7 members and the global community. It should be noted that countries acting alone cannot fully implement infectious disease control and that each country’s interests are adjacent to those of the rest of the world.
Looking to the UN High-Level Meeting in 2024, discussions were center on determining the direction and specific measures required, involving stakeholders from government, industry, academia, and civil society. The focus was on identifying the antibiotic research and development innovation engine.
*Discussion points from this expert meeting will be published in due course.
[Event Overview]
- Date & Time: Tuesday, April 23, 2024, from 18:00 to 20:00 JST
- Venue: Global Business Hub Tokyo *In-person attendance only; no online participation is available
(1 Chome-9-2 Otemachi, Chiyoda City, Tokyo, JAPAN 100-0004) - Language: Japanese and English, with simultaneous interpretation
[Program] (titles omitted; in no particular order)
18:00-18:10 | Opening Remarks |
Yasuhisa Shiozaki (Member of the Global Leaders Group on Antimicrobial Resistance/ Former Minister of Health, Labour and Welfare, Japan) Drew Ferguson (The United States House of Representative) |
|
18:10-18:20 | Explanatory Introduction |
Ryoji Noritake (CEO, Board Member, Health and Global Policy Institute (HGPI)) Yui Kohno (Manager, HGPI) |
|
18:20-19:50 | Discussion “Race Against Resistance – What Will Happen When Drug Resistance Spreads?” |
(All speakers and attendees at the venue) Designated Remarks: Norio Ohmagari (Director, AMR Clinical Reference Center, National Center for Global Health and Medicine (NCGM)) Keiji Okinaka (Chief, Division of Infectious Diseases (ID) and Infection Control and Prevention section, National Cancer Center Hospital East (NCCHE) / Staff, Division of Hematopoietic Stem Cell Transplantation (HSCT), National Cancer Center Hospital (NCCH)) Jun Sugihara (Principal Deputy Director / Director, Office of Ending AIDS Epidemic and Director, Office of Tuberculosis Elimination, Division of Infectious Disease Prevention and Control, Department of Infectious Disease Prevention and Control, Public Health Bureau, Ministry of Health, Labour and Welfare) Takuko Sawada (Director and Vice Chairperson of the Board, Shionogi & Co., Ltd) Henry Skinner (CEO, AMR Action Fund) |
|
19:50-20:00 | Closing |
日本語
Top Research & Recommendations Posts
- [Announcement] HGPI Joins Alliance for Transformative Action on Climate and Health (April 22, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Publication Report] Developing and Expanding Cardiovascular Disease Control Plans in Each Prefecture – Challenges and Good Examples for Cardiovascular Disease Control (September 7, 2023)
- [Event Report] Planetary Health Expert Meeting Aiming for Sustainable Healthcare: Learning from the Impact of Environmental Pollution and Medical Waste During the Pandemic (February 16, 2024)
- [Public Comment Submission] Opinions Regarding the Proposed “National Action Plan on Antimicrobial Resistance 2023-2027 (Draft)” (March 16, 2023)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
Featured Posts
-
2024-04-22
[Registration Open] (Hybrid Format) Intractable Disease Day Symposium: Future Measures for Intractable Diseases from the Perspectives of Patients and Citizens (May, 23 2024)
-
2024-04-23
[Registration Open] (Webinar) The 125th HGPI Seminar: Progress and Prospects for Domestic Measures on Health Problems Caused by Alcohol (May 24 , 2024)
-
2024-04-30
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Community Development for Senior Health: From Establishing Evidence to Social Implementation” (April 23, 2024)
-
2024-05-02
[Event Report] The 123rd HGPI Seminar – The Current Situation and Future Prospects for Epilepsy in Japan and Around the World (March 6, 2024)
-
2024-05-09
[Registration Open] The Health Policy Academy the 13th Session